156 related articles for article (PubMed ID: 30912338)
1. Myths about Insulin Resistance: Tribute to Gerald Reaven.
Kim SH; Abbasi F
Endocrinol Metab (Seoul); 2019 Mar; 34(1):47-52. PubMed ID: 30912338
[TBL] [Abstract][Full Text] [Related]
2. Metformin and improvement of the hepatic insulin resistance index independent of anthropometric changes.
Gómez-Sámano MÁ; Gulias-Herrero A; Cuevas-Ramos D; Brau-Figueroa H; Mehta R; Vargas-Gutiérrez D; Meza-Arana CE; Nieves-Niebla JM; Vázquez-Hernández MO
Endocr Pract; 2012; 18(1):8-16. PubMed ID: 21742607
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.
Ehret M; Goethe J; Lanosa M; Coleman CI
J Clin Psychiatry; 2010 Oct; 71(10):1286-92. PubMed ID: 20441727
[TBL] [Abstract][Full Text] [Related]
6. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
7. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
[TBL] [Abstract][Full Text] [Related]
8. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
10. Role of metformin in type II diabetes.
Epstein S
Cleve Clin J Med; 1995; 62(5):278-9. PubMed ID: 7586481
[No Abstract] [Full Text] [Related]
11. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
[TBL] [Abstract][Full Text] [Related]
12. Early insulin resistance predicts weight gain and waist circumference increase in first-episode psychosis--A one year follow-up study.
Keinänen J; Mantere O; Kieseppä T; Mäntylä T; Torniainen M; Lindgren M; Sundvall J; Suvisaari J
Schizophr Res; 2015 Dec; 169(1-3):458-463. PubMed ID: 26589392
[TBL] [Abstract][Full Text] [Related]
13. Metformin: diamonds are forever.
Papanas N; Maltezos E; Mikhailidis DP
Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
[TBL] [Abstract][Full Text] [Related]
14. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
[TBL] [Abstract][Full Text] [Related]
15. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
16. Metformin and insulin-resistant related diseases: Emphasis on the role of microRNAs.
Alimoradi N; Firouzabadi N; Fatehi R
Biomed Pharmacother; 2021 Jul; 139():111662. PubMed ID: 34243629
[TBL] [Abstract][Full Text] [Related]
17. The mystery of metformin.
Spiering MJ
J Biol Chem; 2019 Apr; 294(17):6689-6691. PubMed ID: 31028160
[No Abstract] [Full Text] [Related]
18. Discordant effects on central obesity, hepatic insulin resistance, and alanine aminotransferase of low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance.
Retnakaran R; Ye C; Hanley AJ; Harris SB; Zinman B
Diabetes Obes Metab; 2012 Jan; 14(1):91-3. PubMed ID: 21812893
[TBL] [Abstract][Full Text] [Related]
19. Gerald M. Reaven, MD: Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease.
Kraemer FB; Ginsberg HN
Diabetes Care; 2014; 37(5):1178-81. PubMed ID: 24757223
[No Abstract] [Full Text] [Related]
20. Pioglitazone metabolic effect in metformin-intolerant obese patients treated with sibutramine.
Derosa G; Mereu R; Salvadeo SA; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Cicero AF
Intern Med; 2009; 48(5):265-71. PubMed ID: 19252346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
